Back to discover
Disease

Duodenal Neoplasms

Late-stage therapeutic developmentEmerging research
MeSHDuodenal Neoplasms
1
Publications
3
Clinical trials
2023
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

Research2023-07-01Journal of the National Comprehensive Cancer Network : JNCCN

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

2 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
3
All trials
0
Active
1
Late-stage
2
Completed
Late-stage studies

Prevention of Progression of Duodenal Adenomas to Cancer in Patients With Familial Adenomatous Polyposis (FAP)

Phase 2/3 · Completed · Radboud University Medical Center

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 69 cites
Recent publications

Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 69 cites
Major themes4
  • Adenocarcinoma1
  • Ampulla of Vater1
  • Common Bile Duct Neoplasms1
  • Duodenal Neoplasms1
Leading journals1
  • Journal of the National Comprehensive Cancer Network : JNCCN1
Leading researchers8
  • Benson AB1
  • Cardin DB1
  • Chiaro MD1
  • Chiorean EG1
  • Christensen JA1
  • Chung V1
  • Czito B1
  • Darlow SD1
Affiliations (unnormalised)6
  • Abramson Cancer Center at the University of Pennsylvania.1
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.1
  • City of Hope National Medical Center.1
  • Dana-Farber/Brigham and Women's Cancer Center.1
  • Duke Cancer Institute.1
  • Fox Chase Cancer Center.1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Tumors or cancer of the DUODENUM.

Identifiers
MeSHDuodenal Neoplasms
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.